CIBC Private Wealth Group’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
CIBC Private Wealth Group's HALO Position: Q4 2025 in Review
CIBC Private Wealth Group reduced its Halozyme (HALO) stake by 21% in Q4 2025, selling an estimated $40.6K and leaving 2,288 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #1323.
CIBC Private Wealth Group first reported a position in HALO in Q1 2015 and has held it in 26 quarters since. The position peaked at $55.3M in Q3 2024. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.
- CIBC Private Wealth Group held 2,288 shares of Halozyme worth $154K as of Q4 2025.
- CIBC Private Wealth Group sold 603 Halozyme shares in Q4 2025, an estimated $40.6K.
- Halozyme made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1323 holding.
- CIBC Private Wealth Group first reported a position in Halozyme in Q1 2015 and has held it in 26 quarters since.
- CIBC Private Wealth Group's Halozyme position peaked at $55.3M in Q3 2024.
- 617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.
Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.